Emergent’s approach is to achieve balance in the products that we develop through a pipeline comprising innovative vaccines and therapeutics that target diseases worldwide.
Program
CDC Category A Agent
(Undisclosed Disease Area)
Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4
CDC Category B Agent
(Undisclosed Disease Area)
Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4